Login to Your Account



Clinic Roundup


Monday, March 18, 2013
• Diffusion Pharmaceuticals LLC, of Charlottesville, Va., said it completed enrollment in a Phase II trial of trans sodium crocetinate (TSC), an oxygen diffusion-enhancing compound.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription